BDBM316360 US9617226, Example 41::cis-2-[2-(3-Chlorophenyl)-6-[3-(7-oxa-2-azaspiro[3.5]nonan-2-ylmethyl)cyclobutyl]-4-oxo-quinazolin-3-yl]-N-isopropyl-acetamide

SMILES CC(C)NC(=O)Cn1c(nc2ccc(cc2c1=O)[C@@H]1C[C@H](CN2CC3(C2)CCOCC3)C1)-c1cccc(Cl)c1

InChI Key InChIKey=UVQGNDNCVAOYDD-PEPAQOBHSA-N

Data  1 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 316360   

TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316360(US9617226, Example 41 | cis-2-[2-(3-Chlorophenyl)-...)
Affinity DataKi:  5.5nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent